Skip to content
TirzepatideReport

Tirzepatide monograph · Evidence review

Knownwell Tirzepatide Review: Insurance, Cost & Honest Verdict (2026)

An honest 2026 review of Knownwell for tirzepatide — weight-inclusive care co-founded by an obesity specialist, insurance billing, and the pricing gaps.

Researched & written by Alan Pierce · last updated

Clinical Pharmacology Writer

On this page

Editorial pick

CoreAge Rx

$149/mo flat

Doctor-reviewed tirzepatide with one flat price and built-in human support.

Advertising disclosure · we may earn a commission at no extra cost to you.

Check availability
vs median
$120/mo below the $269 median
Market
$109–$429/mo across 396 providers
Dispensed
Compounded tirzepatide (503A)

Popular alternative

Wellorithm

Four compounded formats at one price — injectable or oral dissolving tablet, semaglutide or tirzepatide.

$249/mo

Check Wellorithm availability

Knownwell is a weight-inclusive metabolic and primary care practice, co-founded by obesity-medicine physician Dr. Angela Fitch alongside Brooke Boyarsky Pratt, that treats tirzepatide access as one part of a broader, insurance-billing primary-care relationship rather than a standalone medication subscription. This review covers what Knownwell is, what it dispenses, the brand-versus-compounded distinction, what we could and could not confirm about its cost, and the caveats. Every fact here comes from the company's own published program, checked directly against knownwell.co.

What Knownwell is

Knownwell pairs physical clinics — currently listed in Georgia, Illinois, Massachusetts, and New York, with Texas marked "coming soon" — with nationwide virtual care through its Virtual Clinic. It is co-founded by Dr. Angela Fitch, a recognized obesity-medicine specialist, and positions itself as weight-inclusive primary and metabolic care: dietitians and health coaches alongside prescribing clinicians, rather than a prescription-first funnel. The site states there are no sign-up fees and no membership dues, and that it bills insurance, confirming coverage "once we make sure we're available in your state and covered by your insurance" — language that puts the real eligibility check on intake rather than on the marketing page.

The brand-vs-compounded question

Two very different products share the name tirzepatide:

  • Brand tirzepatide is Eli Lilly's FDA-approved Zepbound (weight management, obstructive sleep apnea) and Mounjaro (type 2 diabetes) — the exact molecule and dose studied in the pivotal trials.
  • Compounded tirzepatide is pharmacy-made, not FDA-approved, and was not the product tested in those trials.

Knownwell prescribes branded, FDA-approved GLP-1 medications — Zepbound, Mounjaro, Wegovy, Ozempic, and Saxenda — rather than a compounded pathway. That is a genuine advantage over compounded-only telehealth startups, and it matters more in 2026 now that the enforcement discretion permitting routine large-scale compounding has ended. The full timeline is in our guide to whether compounded tirzepatide is still legal in 2026.

§ Knownwell — Weight-Inclusive Primary Care

ItemKnownwellNote
MedicationBrand only (Zepbound, Mounjaro, Wegovy, Ozempic, Saxenda)No compounded option
FeesNo sign-up fee, no membership duesVerified
InsuranceBilled; copays "as low as $25" if coveredEligibility confirmed at intake
In-person clinicsGA, IL, MA, NY (TX coming soon)Telehealth nationwide otherwise
Knownwell bills insurance and states copays as low as $25 for covered patients, but does not publish a tirzepatide self-pay figure on the pages we could load live. Brand Zepbound via LillyDirect runs ~$299–$449/month (vials, in effect since December 1, 2025) as a cash-pay benchmark.

What Knownwell costs in 2026

This is the honest gap: on the pages we could load live, Knownwell does not display a specific tirzepatide self-pay price; it points to separate "GLP-1 Pricing" and "Weight Loss Medication Pricing" pages rather than stating a figure on the main site, and describes copays as depending on your specific insurance and state. A prior check of the ranking we track recorded a $349/month brand-Zepbound figure attributed to Knownwell, but we could not independently reconfirm that exact number on a live public page during this review — treat it as a starting point to verify directly, not a firm quote. What we could confirm live: no sign-up fees, no membership dues, and insurance billing with copays the company describes as "as low as $25" for covered patients.

For a cash-price benchmark, LillyDirect sells brand Zepbound self-pay vials at roughly $299–$449/month depending on dose (prices in effect since December 1, 2025; 28-day supply). For the full cash-price and insurance picture, see our Zepbound cost and savings and does insurance cover Zepbound guides.

How the care model holds up

Knownwell's strengths are real: co-founded by a recognized obesity-medicine specialist, branded, FDA-approved medication only, a weight-inclusive primary-care model with dietitians and health coaches rather than a bare prescription funnel, no sign-up fees or membership dues, and insurance billing with copays the company describes as low for covered patients. The trade-offs: no public self-pay price for tirzepatide, so the real cost is unknowable until you clear the eligibility check; physical clinics are limited to four states, with everywhere else served by telehealth only; and no LegitScript or similar accreditation badge is visible on the site. As with any GLP-1 service, confirm continuity of care; tirzepatide carries labeled warnings for acute pancreatitis, gallbladder disease, and a boxed thyroid C-cell tumor warning — see our guides on Zepbound side effects, the gallbladder risk, and the thyroid cancer warning.

Does the drug work? (Separate from the provider)

Judge the provider on price, oversight and disclosure; judge the molecule on its trials. Tirzepatide's are strong — roughly 15–21% of body weight over 72 weeks in SURMOUNT-11, and better than semaglutide head-to-head2 — but they were run on the brand drug at FDA-approved doses. Our tirzepatide evidence guide has the full picture.

The honest verdict

Knownwell is worth pursuing if your priority is brand, FDA-approved tirzepatide inside a weight-inclusive, insurance-billing primary-care relationship led by a respected obesity-medicine specialist — and you're comfortable that the exact price won't be confirmable until intake. The honest reservations are the missing public price, the four-state footprint for in-person care, and no visible third-party accreditation badge. If you want a comparable insurance-first, brand-only model with a published outcomes claim, also see our Form Health review; if you want a flat, comparison-shoppable cash price today, weigh CoreAge Rx. See our best tirzepatide providers ranking and does Medicare cover tirzepatide guide.

Frequently asked questions

How much does tirzepatide cost through Knownwell?

Knownwell does not publish a specific tirzepatide self-pay price on the pages we could load live; it points to separate pricing pages and describes copays as depending on your insurance and state, "as low as $25" for covered patients. A prior check attributed a $349/month brand figure to Knownwell that we could not reconfirm live — verify the exact number directly before committing.

Is Knownwell's tirzepatide brand or compounded?

Brand only. Knownwell prescribes FDA-approved GLP-1 medications — Zepbound, Mounjaro, Wegovy, Ozempic, and Saxenda — rather than a compounded pathway, which puts it on the trial-grade side of the brand-versus-compounded line.

Does Knownwell accept insurance?

Yes. Knownwell says it bills insurance and charges no sign-up fee or membership dues, with copays as low as $25 for covered patients, subject to confirming your state and plan are eligible during intake. It does not publish which specific insurers or plans it's in-network with.

Is Knownwell legit?

Knownwell is co-founded by Dr. Angela Fitch, a recognized obesity-medicine specialist, and runs physical clinics in four states plus nationwide telehealth, with a weight-inclusive primary-care model built around dietitians and health coaches. The main caveats are no public self-pay price for tirzepatide and no visible third-party accreditation badge like LegitScript on the site.

References(2)

  1. Jastreboff AM, Aronne LJ, Ahmad NN, Wharton S, Connery L, Alves B, Kiyosue A, Zhang S, Liu B, Bunck MC, Stefanski A, and the SURMOUNT-1 Investigators (2022). Tirzepatide Once Weekly for the Treatment of Obesity.. New England Journal of Medicine. PMID: 35658024. https://pubmed.ncbi.nlm.nih.gov/35658024/
  2. Aronne LJ, Sattar N, Horn DB, Bays HE, Wharton S, Lin WY, Ahmad NN, Zhang S, Liao R, Bunck MC, Jouravskaya I, Murphy MA, and the SURMOUNT-4 Investigators (2024). Continued Treatment With Tirzepatide for Maintenance of Weight Reduction in Adults With Obesity: The SURMOUNT-4 Randomized Clinical Trial.. JAMA. PMID: 38078870. https://pubmed.ncbi.nlm.nih.gov/38078870/

About the author

Alan Pierce

Clinical Pharmacology Writer

About Tirzepatide Report · How we verify prices · This page last updated August 2026

Medical disclaimer: This content is for general educational purposes only and is not medical advice, diagnosis, or treatment. Always consult a licensed healthcare professional before starting, stopping, or changing any treatment.